Open Payments

STEVEN E FERN

Type
Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology
Where
SULLIVAN, MO
NPI
1417982760
Received
$17,921 in 644 records, 2019 to 2025
As principal investigator
$1,245,629 of research payments to others in 358 records
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2025General payment12$521
2024General payment46$1,453
2023General payment82$1,485
2022General payment89$1,595
2021General payment125$2,804
2020General payment143$7,297
2019General payment147$2,761

By company

CompanyRecordsAmountYears
Intercept Pharmaceuticals, Inc.15$5,3642019–2021
ABBVIE INC.190$3,8032019–2025
Salix Pharmaceuticals, a division of Bausch Health US, LLC103$1,7912019–2024
Janssen Biotech, Inc.61$1,1282019–2025
GENZYME CORPORATION13$6962022–2025
Takeda Pharmaceuticals U.S.A., Inc.39$5612019–2022
Merck Sharp & Dohme LLC21$5052019–2024
UCB, Inc.30$4672019–2021
Romark Laboratories, LC19$3372019–2020
Phathom Pharmaceuticals, Inc.5$3352024
PFIZER INC.18$3162019–2025
Celgene Corporation21$2932021–2024
IRONWOOD PHARMACEUTICALS, INC16$2762019–2021
Gilead Sciences, Inc.8$2082024–2025
Medtronic, Inc.3$1852021–2022
Dova Pharmaceuticals5$1542019
RedHill Biopharma Inc.9$1422020–2023
Braintree Laboratories, Inc.9$1412019–2021
Madrigal Pharmaceuticals2$1252025
Amgen Inc.7$1232020–2024
Novo Nordisk Inc1$1082019
QOL Medical, LLC9$1082019–2023
E.R. Squibb & Sons, L.L.C.1$992021
NESTLE HEALTHCARE NUTRITION INC.5$712020–2023
Alfasigma USA, Inc.4$692020
Ferring Pharmaceuticals Inc.4$602020–2022
Shionogi Inc3$532019
Exact Sciences Corporation3$462024–2025
Lilly USA, LLC2$372024–2025
Shire North American Group Inc2$322019
Sumitomo Pharma America, Inc.2$312024
Fresenius Kabi USA, LLC2$292023–2024
Organon Llc1$282023
Mirum Pharmaceuticals, Inc.2$272023–2024
Otsuka America Pharmaceutical, Inc.1$222025
Janssen Pharmaceuticals, Inc1$212024
ABIOMED1$202024
Ardelyx, Inc.1$192022
Bayer Healthcare Pharmaceuticals Inc.1$172022
Daiichi Sankyo Inc.1$142019
Concordia Pharmaceuticals Inc.1$142019
Allergan, Inc.1$132020
Mauna Kea Technologies, Inc.1$112019

By nature of payment

NatureRecordsAmount
Food and Beverage636$12,833
Honoraria2$4,040
Travel and Lodging3$1,014
Gift1$14
Entertainment1$11
Education1$6

Records

DateCompanyAmountNatureFormProductStudyYear
2025-11-05PFIZER INC.$23Food and BeverageIn-kind items and servicesVELSIPITY Drug, INFLAMMATION;PAIN2025
2025-05-14GENZYME CORPORATION$121Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2025
2025-05-08Janssen Biotech, Inc.$121Food and BeverageIn-kind items and servicesTREMFYA Drug, Immunology2025
2025-03-25Exact Sciences Corporation$14Food and BeverageIn-kind items and servicesCologuard Collection Kit Device, Oncology2025
2025-03-24Gilead Sciences, Inc.$17Food and BeverageIn-kind items and services2025
2025-03-21ABBVIE INC.$14Food and BeverageIn-kind items and servicesVRAYLAR Drug, NEUROSCIENCE2025
2025-03-13Madrigal Pharmaceuticals$103Food and BeverageIn-kind items and servicesREZDIFFRA Drug, LIVER DISEASE2025
2025-03-10Lilly USA, LLC$20Food and BeverageIn-kind items and servicesMOUNJARO Drug, Diabetes2025
2025-01-31Otsuka America Pharmaceutical, Inc.$22Food and BeverageIn-kind items and servicesREXULTI Drug, PSYCHIATRY2025
2025-01-23Madrigal Pharmaceuticals$21Food and BeverageIn-kind items and servicesREZDIFFRA Drug, LIVER DISEASE2025
2025-01-16Exact Sciences Corporation$18Food and BeverageIn-kind items and servicesCologuard Collection Kit Device, Oncology2025
2025-01-14Janssen Biotech, Inc.$21Food and BeverageIn-kind items and servicesTREMFYA Drug, Immunology2025
2024-12-23Salix Pharmaceuticals, a division of Bausch Health US, LLC$13Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2024
2024-12-12ABBVIE INC.$5Food and BeverageIn-kind items and servicesMAVYRET Drug, VIROLOGY2024
2024-12-03Gilead Sciences, Inc.$17Food and BeverageIn-kind items and services2024
2024-11-19ABBVIE INC.$4Food and BeverageIn-kind items and servicesMAVYRET Drug, VIROLOGY2024
2024-10-22ABBVIE INC.$15Food and BeverageIn-kind items and servicesVRAYLAR Drug, NEUROSCIENCE2024
2024-10-21Gilead Sciences, Inc.$16Food and BeverageIn-kind items and services2024
2024-10-09Gilead Sciences, Inc.$118Food and BeverageIn-kind items and servicesLivdelzi Drug, INFLAM2024
2024-10-04Janssen Biotech, Inc.$15Food and BeverageIn-kind items and servicesTREMFYA Drug, Immunology2024
2024-10-01Janssen Biotech, Inc.$20Food and BeverageIn-kind items and servicesTREMFYA Drug, Immunology2024
2024-09-26Salix Pharmaceuticals, a division of Bausch Health US, LLC$14Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2024
2024-09-25Janssen Biotech, Inc.$118Food and BeverageIn-kind items and servicesTREMFYA Drug, Immunology2024
2024-09-19ABBVIE INC.$84Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2024
2024-09-19Gilead Sciences, Inc.$16Food and BeverageIn-kind items and services2024
2024-09-19ABBVIE INC.$7Food and BeverageIn-kind items and servicesMAVYRET Drug, VIROLOGY2024
2024-09-19Gilead Sciences, Inc.$1Food and BeverageIn-kind items and services2024
2024-09-10Celgene Corporation$19Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2024
2024-09-05ABBVIE INC.$109Food and BeverageIn-kind items and servicesVRAYLAR Drug, NEUROSCIENCE2024
2024-08-28Phathom Pharmaceuticals, Inc.$109Food and BeverageIn-kind items and servicesVOQUEZNA Drug, GASTROENTEROLOGY2024
2024-08-27Sumitomo Pharma America, Inc.$16Food and BeverageIn-kind items and servicesGEMTESA Drug, UROLOGY2024
2024-08-16Phathom Pharmaceuticals, Inc.$13Food and BeverageIn-kind items and servicesVOQUEZNA Drug, GASTROENTEROLOGY2024
2024-07-29Celgene Corporation$19Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2024
2024-07-22GENZYME CORPORATION$38Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2024
2024-07-16Amgen Inc.$19Food and BeverageIn-kind items and servicesKRYSTEXXA Biological, Inflammation/Rare Disease2024
2024-07-02Salix Pharmaceuticals, a division of Bausch Health US, LLC$14Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2024
2024-07-01ABBVIE INC.$4Food and BeverageIn-kind items and servicesMAVYRET Drug, VIROLOGY2024
2024-06-25GENZYME CORPORATION$23Food and BeverageIn-kind items and servicesFABRAZYME Biological, Genetic Disease2024
2024-06-18Phathom Pharmaceuticals, Inc.$73Food and BeverageIn-kind items and servicesVOQUEZNA Drug, GASTROENTEROLOGY2024
2024-06-18Lilly USA, LLC$17Food and BeverageIn-kind items and servicesMOUNJARO Drug, Diabetes2024
2024-06-11Janssen Pharmaceuticals, Inc$21Food and BeverageIn-kind items and servicesXARELTO Drug, Cardiovascular & Metabolism2024
2024-06-06Sumitomo Pharma America, Inc.$15Food and BeverageIn-kind items and servicesGEMTESA Drug, UROLOGY2024
2024-05-23Phathom Pharmaceuticals, Inc.$125Food and BeverageIn-kind items and servicesVOQUEZNA Drug, GASTROENTEROLOGY2024
2024-05-23Exact Sciences Corporation$14Food and BeverageIn-kind items and servicesCologuard Collection Kit Device, Oncology2024
2024-05-14ABBVIE INC.$9Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2024
2024-05-13GENZYME CORPORATION$42Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2024
2024-05-10Merck Sharp & Dohme LLC$13Food and BeverageIn-kind items and servicesVERQUVO Drug, CARDIOVASCULAR2024
2024-04-19Phathom Pharmaceuticals, Inc.$14Food and BeverageIn-kind items and servicesVOQUEZNA Drug, GASTROENTEROLOGY2024
2024-04-04Janssen Biotech, Inc.$13Food and BeverageIn-kind items and servicesSTELARA Biological, Immunology2024
2024-03-22ABIOMED$20Food and BeverageIn-kind items and servicesImpella Device, Cardiology/Vascular Diseases2024
2024-03-21Gilead Sciences, Inc.$18Food and BeverageIn-kind items and services2024
2024-03-20Gilead Sciences, Inc.$1Food and BeverageIn-kind items and services2024
2024-03-07Fresenius Kabi USA, LLC$14Food and BeverageIn-kind items and servicesIDACIO Biological, Biosimilars2024
2024-02-27Janssen Biotech, Inc.$11Food and BeverageIn-kind items and servicesSTELARA Biological, Immunology2024
2024-02-12Mirum Pharmaceuticals, Inc.$14Food and BeverageIn-kind items and servicesLivmarli Drug, Alagille syndrome2024
2024-02-02GENZYME CORPORATION$117Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2024
2024-01-23Salix Pharmaceuticals, a division of Bausch Health US, LLC$19Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2024
2024-01-10Salix Pharmaceuticals, a division of Bausch Health US, LLC$17Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2024
2023-12-19Salix Pharmaceuticals, a division of Bausch Health US, LLC$19Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2023
2023-12-13ABBVIE INC.$18Food and BeverageIn-kind items and servicesLINZESS Drug, GASTROENTEROLOGY2023
2023-12-06ABBVIE INC.$7Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-11-27Janssen Biotech, Inc.$21Food and BeverageIn-kind items and servicesSTELARA Biological, Immunology2023
2023-11-23PFIZER INC.$18Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2023
2023-11-20ABBVIE INC.$9Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-11-17PFIZER INC.$15Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2023
2023-11-14GENZYME CORPORATION$14Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2023
2023-11-03GENZYME CORPORATION$8Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2023
2023-11-01Salix Pharmaceuticals, a division of Bausch Health US, LLC$18Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2023
2023-10-23GENZYME CORPORATION$32Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2023
2023-10-19Celgene Corporation$13Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2023
2023-10-11PFIZER INC.$18Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2023
2023-10-11PFIZER INC.$17Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2023
2023-10-11Fresenius Kabi USA, LLC$15Food and BeverageIn-kind items and servicesIDACIO Biological, Biosimilars2023
2023-10-11ABBVIE INC.$10Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-10-10ABBVIE INC.$22Food and BeverageIn-kind items and servicesLINZESS Drug, GASTROENTEROLOGY2023
2023-10-09ABBVIE INC.$28Food and BeverageIn-kind items and servicesUBRELVY Drug, NEUROSCIENCE2023
2023-10-02NESTLE HEALTHCARE NUTRITION INC.$15Food and BeverageIn-kind items and servicesZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY2023
2023-09-28ABBVIE INC.$20Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-09-22Mirum Pharmaceuticals, Inc.$13Food and BeverageIn-kind items and servicesLivmarli Drug, Alagille syndrome2023
2023-09-15ABBVIE INC.$21Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-09-13QOL Medical, LLC$5Food and BeverageCash or cash equivalentSucraid Drug, THERAPY FOR CSID2023
2023-09-06ABBVIE INC.$13Food and BeverageIn-kind items and servicesLINZESS Drug, GASTROENTEROLOGY2023
2023-08-30ABBVIE INC.$16Food and BeverageIn-kind items and servicesSKYRIZI Biological, IMMUNOLOGY2023
2023-08-25ABBVIE INC.$14Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-08-23Salix Pharmaceuticals, a division of Bausch Health US, LLC$22Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2023
2023-08-21GENZYME CORPORATION$18Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2023
2023-08-05PFIZER INC.$21Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2023
2023-08-02ABBVIE INC.$31Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-07-31NESTLE HEALTHCARE NUTRITION INC.$15Food and BeverageIn-kind items and servicesZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY2023
2023-07-26Salix Pharmaceuticals, a division of Bausch Health US, LLC$18Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2023
2023-07-24Celgene Corporation$16Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2023
2023-07-11ABBVIE INC.$18Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-07-07GENZYME CORPORATION$12Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2023
2023-06-28ABBVIE INC.$19Food and BeverageIn-kind items and servicesLINZESS Drug, GASTROENTEROLOGY2023
2023-06-23Celgene Corporation$19Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2023
2023-06-21ABBVIE INC.$3Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-06-21ABBVIE INC.$2Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-06-14Salix Pharmaceuticals, a division of Bausch Health US, LLC$20Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2023
2023-06-13QOL Medical, LLC$23Food and BeverageCash or cash equivalentSucraid Drug, THERAPY FOR CSID2023
2023-06-06ABBVIE INC.$19Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-06-05Celgene Corporation$13Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2023
2023-06-03ABBVIE INC.$13Food and BeverageIn-kind items and servicesVIBERZI Drug, GASTROENTEROLOGY2023
2023-05-31NESTLE HEALTHCARE NUTRITION INC.$16Food and BeverageIn-kind items and servicesZENPEP Drug, ENDOCRINE PANCREATIC INSUFFICIENCY2023
2023-05-31ABBVIE INC.$4Food and BeverageIn-kind items and servicesSKYRIZI Biological, IMMUNOLOGY2023
2023-05-24ABBVIE INC.$10Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-05-23ABBVIE INC.$28Food and BeverageIn-kind items and servicesUBRELVY Drug, NEUROSCIENCE2023
2023-05-23Janssen Biotech, Inc.$19Food and BeverageIn-kind items and servicesSTELARA Biological, Immunology2023
2023-05-15Celgene Corporation$14Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2023
2023-05-08ABBVIE INC.$21Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-05-02RedHill Biopharma Inc.$18Food and BeverageCash or cash equivalentMovantik Drug, Opioid Antagonist2023
2023-05-02PFIZER INC.$17Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2023
2023-05-01ABBVIE INC.$6Food and BeverageIn-kind items and servicesMAVYRET Drug, VIROLOGY2023
2023-04-28Celgene Corporation$13Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2023
2023-04-27ABBVIE INC.$24Food and BeverageIn-kind items and servicesSKYRIZI Biological, IMMUNOLOGY2023
2023-04-27ABBVIE INC.$13Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-04-26Janssen Biotech, Inc.$20Food and BeverageIn-kind items and servicesSTELARA Biological, Immunology2023
2023-04-26Salix Pharmaceuticals, a division of Bausch Health US, LLC$9Food and BeverageIn-kind items and servicesTRULANCE Drug, Gastroenterology2023
2023-04-24PFIZER INC.$16Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2023
2023-04-19ABBVIE INC.$16Food and BeverageIn-kind items and servicesVRAYLAR Drug, NEUROSCIENCE2023
2023-04-19ABBVIE INC.$9Food and BeverageIn-kind items and servicesSKYRIZI Biological, IMMUNOLOGY2023
2023-04-12ABBVIE INC.$18Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-04-10Salix Pharmaceuticals, a division of Bausch Health US, LLC$18Food and BeverageIn-kind items and servicesTRULANCE Drug, Gastroenterology2023
2023-04-03ABBVIE INC.$6Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-03-23ABBVIE INC.$10Food and BeverageIn-kind items and servicesSKYRIZI Biological, IMMUNOLOGY2023
2023-03-21GENZYME CORPORATION$120Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2023
2023-03-19ABBVIE INC.$19Food and BeverageIn-kind items and servicesLINZESS Drug, GASTROENTEROLOGY2023
2023-03-17Organon Llc$28Food and BeverageIn-kind items and servicesRENFLEXIS Drug, INFLIXIMAB2023
2023-03-09ABBVIE INC.$10Food and BeverageIn-kind items and servicesSKYRIZI Biological, IMMUNOLOGY2023
2023-03-07ABBVIE INC.$5Food and BeverageIn-kind items and servicesMAVYRET Drug, VIROLOGY2023
2023-02-23ABBVIE INC.$18Food and BeverageIn-kind items and servicesCREON Drug, ENDOCRINOLOGY2023
2023-02-22ABBVIE INC.$7Food and BeverageIn-kind items and servicesSKYRIZI Biological, IMMUNOLOGY2023
2023-02-10QOL Medical, LLC$10Food and BeverageCash or cash equivalentSucraid Drug, THERAPY FOR CSID2023
2023-02-08Salix Pharmaceuticals, a division of Bausch Health US, LLC$19Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2023
2023-02-07ABBVIE INC.$15Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-02-02ABBVIE INC.$97Food and BeverageIn-kind items and servicesVRAYLAR Drug, NEUROSCIENCE2023
2023-02-02ABBVIE INC.$7Food and BeverageIn-kind items and servicesLINZESS Drug, GASTROENTEROLOGY2023
2023-01-30ABBVIE INC.$5Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2023
2023-01-23ABBVIE INC.$12Food and BeverageIn-kind items and servicesCREON Drug, ENDOCRINOLOGY2023
2023-01-19ABBVIE INC.$7Food and BeverageIn-kind items and servicesMAVYRET Drug, VIROLOGY2023
2023-01-18Salix Pharmaceuticals, a division of Bausch Health US, LLC$20Food and BeverageIn-kind items and servicesTRULANCE Drug, Gastroenterology2023
2022-12-19ABBVIE INC.$11Food and BeverageIn-kind items and servicesSKYRIZI Biological, IMMUNOLOGY2022
2022-12-15PFIZER INC.$16Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2022
2022-11-29Janssen Biotech, Inc.$19Food and BeverageIn-kind items and servicesSTELARA Biological, Immunology2022
2022-11-18ABBVIE INC.$7Food and BeverageIn-kind items and servicesMAVYRET Drug, VIROLOGY2022
2022-11-10PFIZER INC.$15Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2022
2022-11-02PFIZER INC.$21Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2022
2022-10-23GENZYME CORPORATION$24Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2022
2022-10-22ABBVIE INC.$14Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2022
2022-10-12Salix Pharmaceuticals, a division of Bausch Health US, LLC$11Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2022
2022-10-11PFIZER INC.$15Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2022
2022-09-28ABBVIE INC.$4Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2022
2022-09-27Janssen Biotech, Inc.$17Food and BeverageIn-kind items and servicesSTELARA Biological, Immunology2022
2022-09-27Celgene Corporation$10Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2022
2022-09-20ABBVIE INC.$16Food and BeverageIn-kind items and servicesSKYRIZI Biological, IMMUNOLOGY2022
2022-09-19Bayer Healthcare Pharmaceuticals Inc.$17Food and BeverageIn-kind items and servicesMirena Drug, Womens Health2022
2022-09-15ABBVIE INC.$97Food and BeverageIn-kind items and servicesQULIPTA Drug, NEUROSCIENCE2022
2022-09-15ABBVIE INC.$5Food and BeverageIn-kind items and servicesQULIPTA Drug, NEUROSCIENCE2022
2022-09-13Takeda Pharmaceuticals U.S.A., Inc.$20Food and BeverageIn-kind items and servicesENTYVIO Biological, INTERNAL MEDICINE2022
2022-09-09QOL Medical, LLC$14Food and BeverageCash or cash equivalentSUCRAID Drug, THERAPY FOR CSID2022
2022-09-08GENZYME CORPORATION$121Food and BeverageIn-kind items and servicesDUPIXENT Biological, Immunology2022
2022-09-08ABBVIE INC.$19Food and BeverageIn-kind items and servicesCREON Drug, ENDOCRINOLOGY2022
2022-09-07Salix Pharmaceuticals, a division of Bausch Health US, LLC$10Food and BeverageIn-kind items and servicesIBSCHEK Device, Gastroenterology2022
2022-09-06ABBVIE INC.$18Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2022
2022-08-29Takeda Pharmaceuticals U.S.A., Inc.$22Food and BeverageIn-kind items and servicesGATTEX Drug, INTERNAL MEDICINE2022
2022-08-26ABBVIE INC.$20Food and BeverageIn-kind items and servicesLINZESS Drug, GASTROENTEROLOGY2022
2022-08-23Janssen Biotech, Inc.$17Food and BeverageIn-kind items and servicesSTELARA Biological, Immunology2022
2022-08-16QOL Medical, LLC$21Food and BeverageCash or cash equivalentSUCRAID Drug, THERAPY FOR CSID2022
2022-08-12ABBVIE INC.$7Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2022
2022-08-10Salix Pharmaceuticals, a division of Bausch Health US, LLC$20Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2022
2022-08-03ABBVIE INC.$18Food and BeverageIn-kind items and servicesLINZESS Drug, GASTROENTEROLOGY2022
2022-07-20ABBVIE INC.$20Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2022
2022-07-15ABBVIE INC.$17Food and BeverageIn-kind items and servicesLINZESS Drug, GASTROENTEROLOGY2022
2022-07-15Celgene Corporation$13Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2022
2022-07-06Janssen Biotech, Inc.$17Food and BeverageIn-kind items and servicesSTELARA Biological, Immunology2022
2022-06-29Celgene Corporation$15Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2022
2022-06-29ABBVIE INC.$8Food and BeverageIn-kind items and servicesSKYRIZI Biological, IMMUNOLOGY2022
2022-06-24ABBVIE INC.$18Food and BeverageIn-kind items and servicesVIBERZI Drug, GASTROENTEROLOGY2022
2022-06-08Salix Pharmaceuticals, a division of Bausch Health US, LLC$12Food and BeverageIn-kind items and servicesXIFAXAN Drug, Gastroenterology2022
2022-05-30PFIZER INC.$16Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2022
2022-05-26Janssen Biotech, Inc.$15Food and BeverageIn-kind items and servicesSTELARA Biological, Immunology2022
2022-05-25ABBVIE INC.$22Food and BeverageIn-kind items and servicesCREON Drug, ENDOCRINOLOGY2022
2022-05-25Celgene Corporation$15Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2022
2022-05-18Salix Pharmaceuticals, a division of Bausch Health US, LLC$10Food and BeverageIn-kind items and servicesTRULANCE Drug, Gastroenterology2022
2022-05-13Celgene Corporation$11Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2022
2022-05-13Celgene Corporation$8Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2022
2022-05-05ABBVIE INC.$18Food and BeverageIn-kind items and servicesLINZESS Drug, GASTROENTEROLOGY2022
2022-05-04ABBVIE INC.$16Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2022
2022-05-03Ardelyx, Inc.$19Food and BeverageIn-kind items and servicesIBSRELA Drug, GASTROENTEROLOGY2022
2022-04-26Janssen Biotech, Inc.$15Food and BeverageIn-kind items and servicesSTELARA Biological, Immunology2022
2022-04-26ABBVIE INC.$1Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2022
2022-04-20ABBVIE INC.$16Food and BeverageIn-kind items and servicesCREON Drug, ENDOCRINOLOGY2022
2022-04-18ABBVIE INC.$14Food and BeverageIn-kind items and servicesHUMIRA Biological, IMMUNOLOGY2022
2022-04-16Ferring Pharmaceuticals Inc.$16Food and BeverageIn-kind items and servicesCIMZIA Drug, GASTROENTEROLOGY2022
2022-04-14Celgene Corporation$10Food and BeverageCash or cash equivalentZEPOSIA Drug, Neuroscience2022
2022-04-12ABBVIE INC.$24Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2022
2022-04-11Medtronic, Inc.$68Food and BeverageIn-kind items and servicesGI GENIUS Device, Gastrointestinal AI2022
2022-04-08ABBVIE INC.$22Food and BeverageIn-kind items and servicesVIBERZI Drug, GASTROENTEROLOGY2022
2022-03-30Salix Pharmaceuticals, a division of Bausch Health US, LLC$5Food and BeverageIn-kind items and servicesPLENVU Drug, Gastroenterology2022
2022-03-29ABBVIE INC.$23Food and BeverageIn-kind items and servicesRINVOQ Biological, IMMUNOLOGY2022
2022-03-24PFIZER INC.$16Food and BeverageIn-kind items and servicesXELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT2022

The latest 200 records of 644.

Research payments naming this person as principal investigator

DateCompanyPaid toAmountStudyYear
2025-06-18Vanda Pharmaceuticals Inc.CLINICAL RESEARCH PROFESSIONALS INC$100SINGLE-PATIENT EXPANDED ACCESS PROTOCOL FOR TRADIPITANT IN A SINGLE PATIENT WITH GASTROPARESIS2025
2025-06-18Vanda Pharmaceuticals Inc.CLINICAL RESEARCH PROFESSIONALS INC$2,500SINGLE-PATIENT EXPANDED ACCESS PROTOCOL FOR TRADIPITANT IN A SINGLE PATIENT WITH GASTROPARESIS2025
2025-04-09Vanda Pharmaceuticals Inc.CLINICAL RESEARCH PROFESSIONALS INC$1,000SINGLE-PATIENT EXPANDED ACCESS PROTOCOL FOR TRADIPITANT IN A SINGLE PATIENT WITH GASTROPARESIS2025
2025-01-23E.R. Squibb & Sons, L.L.C.Clinical Research Professionals$11,569A Phase 3, Multicenter, Open-Label Extension Trial of Oral RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis2025
2024-12-31Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-12-31Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-12-31Braintree Laboratories, Inc.Clinical Research Professionals$2,942A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-12-23Vanda Pharmaceuticals Inc.CLINICAL RESEARCH PROFESSIONALS INC$1,500EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS2024
2024-12-19E.R. Squibb & Sons, L.L.C.Clinical Research Professionals$4,003PhIII RPC1063 Open Label Extension Moderate to Severe in UC (RPC01-3102) - A Phase 3, Multicenter, Open-Label Extension 2024
2024-12-18Braintree Laboratories, Inc.Clinical Research Professionals$3,030A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-12-18Braintree Laboratories, Inc.Clinical Research Professionals$3,030A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-12-10Braintree Laboratories, Inc.Clinical Research Professionals$5,266A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-12-04Vanda Pharmaceuticals Inc.CLINICAL RESEARCH PROFESSIONALS INC$1,000EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS2024
2024-11-18Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$500A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-11-06Braintree Laboratories, Inc.Clinical Research Professionals$6,730A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-10-24Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$744A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-10-11Braintree Laboratories, Inc.Clinical Research Professionals$3,500A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-10-09Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$100A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-10-08Braintree Laboratories, Inc.Clinical Research Professionals$9,090A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-10-04Braintree Laboratories, Inc.Clinical Research Professionals$400A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-10-03Braintree Laboratories, Inc.Clinical Research Professionals$8,755A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-10-03Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$1,519A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-09-19Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-09-19Braintree Laboratories, Inc.Clinical Research Professionals$100A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-09-19Braintree Laboratories, Inc.Clinical Research Professionals$3,030A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-09-19Braintree Laboratories, Inc.Clinical Research Professionals$1,400A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-09-19Braintree Laboratories, Inc.Clinical Research Professionals$15,150A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-09-19Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$5,200A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-09-19Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$400A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-09-17Braintree Laboratories, Inc.Clinical Research Professionals$5,173A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-08-28Braintree Laboratories, Inc.Clinical Research Professionals$3,030A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-08-28Braintree Laboratories, Inc.Clinical Research Professionals$2,100A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-08-22Braintree Laboratories, Inc.Clinical Research Professionals$3,030A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-08-16Braintree Laboratories, Inc.Clinical Research Professionals$9,090A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-08-16Braintree Laboratories, Inc.Clinical Research Professionals$1,785A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-08-14Braintree Laboratories, Inc.Clinical Research Professionals$2,100A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-08-14Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$744A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-08-14Braintree Laboratories, Inc.Clinical Research Professionals$6,060A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-08-02Braintree Laboratories, Inc.Clinical Research Professionals$6,060A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-08-02Braintree Laboratories, Inc.Clinical Research Professionals$2,800A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-08-02Braintree Laboratories, Inc.Clinical Research Professionals$400A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-08-01Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$400A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-07-31Braintree Laboratories, Inc.Clinical Research Professionals$3,030A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-31Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-31Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-31Braintree Laboratories, Inc.Clinical Research Professionals$3,030A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-31Braintree Laboratories, Inc.Clinical Research Professionals$1,400A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-31Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-25Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$2,898A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-07-19Braintree Laboratories, Inc.Clinical Research Professionals$3,500A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-19Braintree Laboratories, Inc.Clinical Research Professionals$3,030A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-19Braintree Laboratories, Inc.Clinical Research Professionals$3,030A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-19Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-19Braintree Laboratories, Inc.Clinical Research Professionals$1,785A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-19Braintree Laboratories, Inc.Clinical Research Professionals$6,060A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-19Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-19Braintree Laboratories, Inc.Clinical Research Professionals$3,030A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-19Braintree Laboratories, Inc.Clinical Research Professionals$3,030A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-19Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-19Braintree Laboratories, Inc.Clinical Research Professionals$3,030A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-19Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-15Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-15Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-15Braintree Laboratories, Inc.Clinical Research Professionals$1,400A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-15Braintree Laboratories, Inc.Clinical Research Professionals$2,100A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-15Braintree Laboratories, Inc.Clinical Research Professionals$700A PHASE 3, Double-Blind, Randomized, Two-Phase, Active-Controlled Study to Evaluate the Efficacy and Safety of Tegopraza2024
2024-07-10Vanda Pharmaceuticals Inc.CLINICAL RESEARCH PROFESSIONALS INC$2,478EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS2024
2024-06-21Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$400A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-06-21Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$400A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-06-19Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$1,519A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-06-13Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$7,215A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-06-13Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$7,215A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-06-07Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$400A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-05-09Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$50A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-05-09Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$50A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-05-09Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$50A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-05-09Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$400A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-05-09Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$50A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-05-09Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$400A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-05-02Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$100A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-04-25Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$800A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-04-24E.R. Squibb & Sons, L.L.C.Clinical Research Professionals$4,106A Phase 4, Global, Prospective, Open label Study of Ozanimod to Explore the Safety, Efficacy, Quality of Life, and Bioma2024
2024-04-19Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$400A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-04-17Vanda Pharmaceuticals Inc.CLINICAL RESEARCH PROFESSIONALS INC$1,000EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS2024
2024-04-15Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$2,282A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-04-15Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$90A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-03-14Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$5,110A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-03-14Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$3,239A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-03-14Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$3,239A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-03-04Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$71A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-02-08Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$1,532A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-02-08Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$1,532A PHASE 3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tegoprazan in Patie2024
2024-02-07Celgene CorporationClinical Research Professionals$1,200PhIII RPC1063 Open Label Extension Moderate to Severe in UC (RPC01-3102) - A Phase 3, Multicenter, Open-Label Extension 2024
2024-01-25E.R. Squibb & Sons, L.L.C.Clinical Research Professionals$349An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice2024
2024-01-24Vanda Pharmaceuticals Inc.CLINICAL RESEARCH PROFESSIONALS INC$2,478EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS2024
2024-01-15Braintree Laboratories, Inc.CLINICAL RESEARCH PROFESSIONALS LLC$2,555A PHASE-3, Double-Blind, 29-Week Follow-Up Study to Evaluate the Long-Term Safety of Tegoprazan in Patients with Gastroe2024
2024-01-10Vanda Pharmaceuticals Inc.CLINICAL RESEARCH PROFESSIONALS INC$279EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS2024
2024-01-10Vanda Pharmaceuticals Inc.CLINICAL RESEARCH PROFESSIONALS INC$136EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS2024
2024-01-10Vanda Pharmaceuticals Inc.CLINICAL RESEARCH PROFESSIONALS INC$584EVALUATING THE SAFETY AND EFFICACY OF TRADIPITANT VS. PLACEBO IN IDIOPATHIC AND DIABETIC GASTROPARESIS2024
2024-01-10Vanda Pharmaceuticals Inc.CLINICAL RESEARCH PROFESSIONALS INC$413SINGLE-PATIENT EXPANDED ACCESS PROTOCOL FOR TRADIPITANT IN A SINGLE PATIENT WITH GASTROPARESIS2024

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Franklin CountySullivan city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Sullivan, MO, county Franklin County, MO, state Missouri; placed by its city name.

MeasurePlace (city or town)
Sullivan, MO
County
Franklin County, MO
State
Missouri
Population B010036,310105,9506,191,814
Population, 2020 census P16,906104,6826,154,913
Median age B0100239.441.839.0
Under 18 B0100124.1%22.4%22.3%
65 and over B0100120.3%19.2%17.9%
Households B110012,72243,0362,508,227
Foreign born B050020.1%1.4%4.5%
Median household income B19013$63,370$73,165$70,702
Median family income B19113$85,060$90,136$91,360
Per capita income B19301$32,875$37,792$39,695
Poverty rate B1700111.4%8.2%12.6%
Unemployment rate B230255.9%4.3%4.0%
Civilian labor force B230253,13252,9513,120,639
Mean commute (minutes) B0801321.828.323.5
Bachelor's degree or higher B1500318.9%23.7%32.4%
Housing units B250012,92046,3122,825,287
Owner-occupied B2500362.4%76.5%68.1%
Renters B2500337.6%23.5%31.9%
Median home value B25077$163,200$227,600$230,300
Median gross rent B25064$919$893$1,033
White, not Hispanic B0300287.7%88.7%76.3%
Black B030021.5%0.9%10.9%
Hispanic or Latino B030020.8%2.3%5.2%
Asian B030020.0%0.4%2.1%
American Indian and Alaska Native B030020.1%0.1%0.2%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Sullivan, MO.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.